Webinar - Biosimilars

[Carol_MacularSociety]

Professor of Ophthalmology Richard Gale from the Hull York Medical School, will be joining us for our next My Macular and Me webinar, to discuss the introduction of biosimilars on the NHS.

A biosimilar is a medicine that is developed to be highly similar to an existing biological medicine. They might vary slightly from the original brand of medicine but they work in the same way and they are equally safe and effective. Patients are starting to be offered the cheaper anti-VEGF drugs, as existing medicines are no longer subject to patent

Biosimilars are important as copying a successful medicine is much quicker and cheaper than developing a new one as the original has already been proven to work. This means biosimilars are usually less expensive, even though the quality is the same.

Join our webinar to hear more from Professor Richard Gale and his research on biosimilars. This My Macular and Me webinar will be taking place on Tuesday 18th April at 7pm.

To register please see the link below

macularsociety.org/support/...

Kind regards,

Carol

Macular Society Advice and Information Service

[tallyho]

hi Carol I have seen this advertised as an AMD event when in fact it is for both AMD and working age patients by similes are used in both categories. You have not differentiated here which is great but it is differentiated on the website. Just letting you know, thank you very much. I look forward to this, especially as I was involved in a technology appraisal for Faricimab which is a biosimilar, thank you very much

[eyeglass]

Hi Carol, are these talks recorded and available to view after the event? Thanks

[Carol_MacularSociety Partner in reply to eyeglass]

Dear eyeglass,

Our webinars are all posted on our website a few days after the live event. Please see the link below

macularsociety.org/support/...

Kind regards,

Carol

Macular Society Advice and Information Service

[eyeglass]

Thank you, Carol